Xeloda · DIN 02238453 · 150 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.Discontinued December 7, 2022 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-12-07 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Xeloda · DIN 02238453
Manufacturer: Hoffmann-La Roche Limited; listing date 2001-06-07
Health Canada: Cancelled post market since 2022-12-07 · brand XELODA · ATC L01BC06 CAPECITABINE · form Tablet · route Oral · ingredients CAPECITABINE 150 MG · company Cheplapharm arzneimittel gmbh · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02238453)
Source record
DIN 02238453: Xeloda
Raw flags: sec3=Y
Item: 100000136; group id 149; item number 0252; lccId None; manufacturer id HLR
Source form: Tab; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $1.9478; ministry $0.4575
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02238453
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=61873
Interchangeable products
Ach-Capecitabine · DIN 02426757 · $0.4575
Capecitabine · DIN 02514982 · $0.4575
Capecitabine · DIN 02519879 · $0.4575
Sandoz Capecitabine · DIN 02421917 · $0.4575
Taro-Capecitabine · DIN 02457490 · $0.4575
Teva-Capecitabine · DIN 02400022 · $0.4575
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since December 7, 2022 — choose a marketed DIN from the same-category list.